These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 18958745)

  • 1. Is there a role for mesenchymal stem cells in autoimmune diseases?
    Uccelli A; Mancardi G; Chiesa S
    Autoimmunity; 2008 Dec; 41(8):592-5. PubMed ID: 18958745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cell therapy for degenerative inflammatory disorders.
    Müller I; Lymperi S; Dazzi F
    Curr Opin Organ Transplant; 2008 Dec; 13(6):639-44. PubMed ID: 19060556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks.
    Tyndall A; Uccelli A
    Bone Marrow Transplant; 2009 Jun; 43(11):821-8. PubMed ID: 19308035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stromal cells.
    Bernardo ME; Locatelli F; Fibbe WE
    Ann N Y Acad Sci; 2009 Sep; 1176():101-17. PubMed ID: 19796238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation.
    Reinders ME; Fibbe WE; Rabelink TJ
    Nephrol Dial Transplant; 2010 Jan; 25(1):17-24. PubMed ID: 19861311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications.
    Yi T; Song SU
    Arch Pharm Res; 2012 Feb; 35(2):213-21. PubMed ID: 22370776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit?
    Bouffi C; Djouad F; Mathieu M; Noël D; Jorgensen C
    Rheumatology (Oxford); 2009 Oct; 48(10):1185-9. PubMed ID: 19561159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological properties of mesenchymal stem cells and clinical implications.
    Patel SA; Sherman L; Munoz J; Rameshwar P
    Arch Immunol Ther Exp (Warsz); 2008; 56(1):1-8. PubMed ID: 18250975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases.
    Ben-Ami E; Berrih-Aknin S; Miller A
    Autoimmun Rev; 2011 May; 10(7):410-5. PubMed ID: 21256250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of mesenchymal stem cell therapy.
    Dazzi F; Horwood NJ
    Curr Opin Oncol; 2007 Nov; 19(6):650-5. PubMed ID: 17906466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells: isolation, in vitro expansion and characterization.
    Beyer Nardi N; da Silva Meirelles L
    Handb Exp Pharmacol; 2006; (174):249-82. PubMed ID: 16370331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regenerative and immunomodulatory potential of mesenchymal stem cells.
    Krampera M; Pasini A; Pizzolo G; Cosmi L; Romagnani S; Annunziato F
    Curr Opin Pharmacol; 2006 Aug; 6(4):435-41. PubMed ID: 16777484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis.
    Kassis I; Grigoriadis N; Gowda-Kurkalli B; Mizrachi-Kol R; Ben-Hur T; Slavin S; Abramsky O; Karussis D
    Arch Neurol; 2008 Jun; 65(6):753-61. PubMed ID: 18541795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells: a new strategy for immunosuppression?
    Uccelli A; Pistoia V; Moretta L
    Trends Immunol; 2007 May; 28(5):219-26. PubMed ID: 17400510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.
    Larghero J; Farge D; Braccini A; Lecourt S; Scherberich A; Foïs E; Verrecchia F; Daikeler T; Gluckman E; Tyndall A; Bocelli-Tyndall C
    Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis.
    Constantin G; Marconi S; Rossi B; Angiari S; Calderan L; Anghileri E; Gini B; Bach SD; Martinello M; Bifari F; Galiè M; Turano E; Budui S; Sbarbati A; Krampera M; Bonetti B
    Stem Cells; 2009 Oct; 27(10):2624-35. PubMed ID: 19676124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells.
    Ding DC; Shyu WC; Lin SZ
    Cell Transplant; 2011; 20(1):5-14. PubMed ID: 21396235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of EGFP-labeled mesenchymal stem cells and redistribution of allogeneic cells after subcutaneous implantation.
    Duan X; Yang L; Dong S; Xin R; Chen G; Guo L
    Arch Orthop Trauma Surg; 2008 Jul; 128(7):751-9. PubMed ID: 18265994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation by mesenchymal stem cells and clinical experience.
    Le Blanc K; Ringdén O
    J Intern Med; 2007 Nov; 262(5):509-25. PubMed ID: 17949362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation control of transplanted mesenchymal stem cells (MSCs): a new possible strategy to promote periodontal regeneration.
    Zhao Q; Gong P; Tan Z; Yang X
    Med Hypotheses; 2008; 70(5):944-7. PubMed ID: 18023537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.